China Resources Pharmaceutical Group Limited (FRA:640)

Market Cap	3.54B
Revenue (ttm)	34.10B
Net Income (ttm)	440.83M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	8.03
Forward PE	n/a
Dividend	0.03 (5.70%)
Ex-Dividend Date	May 28, 2025

Volume	3,000
Average Volume	1,800
Open	0.5350
Previous Close	0.5300
Day's Range	0.5350 - 0.5350
52-Week Range	0.5250 - 0.8350
Beta	n/a
RSI	38.54
Earnings Date	Aug 25, 2025

About FRA:640

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and v, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 72,700
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 640

Financial Performance

In 2024, FRA:640's revenue was 257.67 billion, an increase of 5.30% compared to the previous year's 244.70 billion. Earnings were 3.33 billion, a decrease of -13.57%.

Financial numbers in CNY